Shared Decision Making With Pharmaceutical Care

Diabetes Clinical Trial

— SDMPC  

Official title:

Examining the Use of a Shared Decision Making Tool With Pharmaceutical Care in Type 2 Diabetes

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT02373059
• Other study ID #: 14-009665
• Status: Completed
• Phase: N/A
• First received: February 16, 2015
• Last updated: May 6, 2016
• Start date: February 2015
• Est. completion date: June 2015

Study information

• Verified date: May 2016
• Source: Mayo Clinic
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

A research study to enhance clinical discussion between patients and pharmacists using a shared decision making tool for type 2 diabetes or usual care.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 15
• Est. completion date: June 2015
• Est. primary completion date: June 2015
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Adults = 18 years of age

• Diagnosed with type II diabetes by ICD-9 code for more than one year

• HbA1c of 7%-9.5% within past 6 months

• Prescribed three or less anti-hyperglycemic medications as indicated by the medication list within the medical record

Exclusion Criteria:

• Prescribed insulin

• Pregnancy

• Appointment with provider within a month

• Appointment with provider within the last month

• Followed by endocrinology

Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research

Related Conditions & MeSH terms

• Diabetes

Intervention

Other:
• Diabetes Issue Cards Decision Aids

• Usual Pharmaceutical Care

Locations

Country	Name	City	State
United States	Mayo Clinic Kasson	Kasson	Minnesota

Sponsors (1)

Lead Sponsor	Collaborator
Mayo Clinic

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Patient Involvement Questionnaire		Post-Visit up to 2 weeks	No
Secondary	Patient Knowledge regarding Diabetes treatments Questionnaire		post visit up to 2 weeks	No
Secondary	Patient Medication Adherence Questionnaire		1 month post visit	No